1-(1-Cyclopentyl-2-cyclopropylethyl)-1H-pyrazol-4-yl-7H-pyrrolo[2,3-d]pyrimidine trifluoroacetate salt → HCID 66597459, compound
Reaction equation
[F:1][C:2]([F:7])([F:6])[C:3]([OH:5])=[O:4].[CH:8]1([CH:13]([N:18]2[CH:22]=[C:21]([C:23]3[N:24]=[CH:25][C:26]4[CH:31]=[CH:30][NH:29][C:27]=4[N:28]=3)[CH:20]=[N:19]2)[CH2:14][CH:15]2[CH2:17]C2)[CH2:12][CH2:11][CH2:10][CH2:9]1.[H][H]>CO.[Pd]>[F:1][C:2]([F:7])([F:6])[C:3]([OH:5])=[O:4].[CH:8]1([CH:13]([N:18]2[CH:22]=[C:21]([C:23]3[C:31]4[CH:26]=[CH:25][NH:24][C:30]=4[N:29]=[CH:27][N:28]=3)[CH:20]=[N:19]2)[CH2:14][CH2:15][CH3:17])[CH2:9][CH2:10][CH2:11][CH2:12]1Participants
5
Procedure
4-[1-(1-Cyclopentylbut-3-yn-1-yl)-1H-pyrazol-4-yl]-7H-pyrrolo[2,3-d]pyrimidine trifluoro-acetate salt (prepared in Example 729) (20 mg, 0.048 mmol) was dissolved in methanol (2 mL) and a catalytic amount of 5% Pd—C was added. The mixture was stirred under 1 atmosphere of hydrogen via an affixed balloon. After 2 hours, the mixture was filtered and purified via preparative-HPLC/MS (C18 eluting with a gradient of H2O and ACN containing 0.1% TFA) to afford the product (14 mg, 69%).
Workup
- filtrationthe mixture was filtered
- custompurified via preparative-HPLC/MS (C18
- washeluting with a gradient of H2O and ACN containing 0.1% TFA)
Sources & evidence
- ORD record
- ord-2e147711e8104932be6b7beb8a73acf3
- Source dataset
- uspto-grants-2009_10
- Patent number
- US07598257B2
Reaction notes
Loading…